These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23537648)

  • 1. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
    Mohan SK; Gupta AA; Yu C
    Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
    Sung HY; Dowarha D; Chou RH; Yu C
    Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
    Rani SG; Sepuru KM; Yu C
    Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
    Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
    J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking the interaction between S100A9 and RAGE V domain using CHAPS molecule: A novel route to drug development against cell proliferation.
    Chang CC; Khan I; Tsai KL; Li H; Yang LW; Chou RH; Yu C
    Biochim Biophys Acta; 2016 Nov; 1864(11):1558-69. PubMed ID: 27524699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
    Mahajan N; Bahl A; Dhawan V
    Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction.
    Matsumoto S; Yoshida T; Murata H; Harada S; Fujita N; Nakamura S; Yamamoto Y; Watanabe T; Yonekura H; Yamamoto H; Ohkubo T; Kobayashi Y
    Biochemistry; 2008 Nov; 47(47):12299-311. PubMed ID: 19032093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
    Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
    Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring binding of S100 proteins to RAGE by surface plasmon resonance.
    Leclerc E
    Methods Mol Biol; 2013; 963():201-13. PubMed ID: 23296613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
    Penumutchu SR; Chou RH; Yu C
    PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.
    Hsieh HL; Schäfer BW; Weigle B; Heizmann CW
    Biochem Biophys Res Commun; 2004 Apr; 316(3):949-59. PubMed ID: 15033494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
    Chiou JW; Fu B; Chou RH; Yu C
    PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentamidine blocks the interaction between mutant S100A5 and RAGE V domain and inhibits the RAGE signaling pathway.
    Cho CC; Chou RH; Yu C
    Biochem Biophys Res Commun; 2016 Aug; 477(2):188-94. PubMed ID: 27297108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the interaction of human S100B and basic fibroblast growth factor (FGF2): Effects on FGFR1 receptor signaling.
    Gupta AA; Chou RH; Li H; Yang LW; Yu C
    Biochim Biophys Acta; 2013 Dec; 1834(12):2606-19. PubMed ID: 24063890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
    Huang YK; Chou RH; Yu C
    J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100 to receptor for advanced glycation end-products binding assay: looking for inhibitors.
    Padilla L; Dakhel S; Hernández JL
    Biochem Biophys Res Commun; 2014 Mar; 446(1):404-9. PubMed ID: 24613850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli.
    Wilton R; Yousef MA; Saxena P; Szpunar M; Stevens FJ
    Protein Expr Purif; 2006 May; 47(1):25-35. PubMed ID: 16510295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
    Allmen EU; Koch M; Fritz G; Legler DF
    Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular signalling of the receptor for advanced glycation end products (RAGE).
    Xie J; Méndez JD; Méndez-Valenzuela V; Aguilar-Hernández MM
    Cell Signal; 2013 Nov; 25(11):2185-97. PubMed ID: 23838007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
    Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
    J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.